"Partnering with you on your cancer journey. From the moment you receive a cancer diagnosis, you are a survivor. Family, friends and caregivers impacted by cancer, you are co-survivors. We've created a place of healing - high tech and high touch - where research, technology and human interaction come together in a collaborative effort of medical excellence. The words "You have cancer" are life changing. Facing your diagnosis and the winding road ahead through treatment and beyond may leave you feeling out of control and afraid. We're here to help, heal and support. St. Charles Cancer Center brings together leading research, technology and personalized guidance to deliver the highest quality patient care - both physically & emotionally."

During the past decade, St. Charles Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Charles Cancer Center" are "Solid Tumor and Hematologic Malignancies" (1 trials) and "Tumor Pathway Activations Inhibited by Dovitinib" (1 trials). Many other conditions were trialed in "St. Charles Cancer Center" in a lesser frequency.

Most popular intervention types in "St. Charles Cancer Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dovitinib (TKI258)" (1 trials) and "MEK162" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Charles Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "St. Charles Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. Charles Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Charles Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".